Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $3.4M | $3.3M | $2.1M | $177,326 |
| Gross profit | $1.3M | $1.6M | $1.3M | $17,026 |
| Gross margin | 38.26% | 47.28% | 61.05% | 9.60% |
| Research & development | $171,972 | $55,001 | $4,381 | $0 |
| Operating expenses | $3.2M | $940,683 | $233,598 | $220,344 |
| Operating income | −$1.9M | $614,835 | $1.0M | −$203,318 |
| Operating margin | −56.31% | 18.69% | 49.93% | −114.66% |
| EBITDA | −$1.6M | $957,811 | $1.2M | −$199,973 |
| EBITDA margin | −47.37% | 29.11% | 56.68% | −112.77% |
| Net income | −$1.9M | $286,142 | $917,687 | −$205,158 |
| Net profit margin | −55.78% | 8.70% | 43.68% | −115.70% |
| Basic EPSper basic share | — | $0.02 | $0.08 | -$0.02 |
| Diluted EPSper diluted share | — | $0.02 | $0.08 | -$0.02 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
UBS Group AG | 3K |
MORGAN STANLEY | 29 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.